Jeff Yass’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-191,500
Closed -$10.2M 10169
2016
Q1
$10.2M Sell
191,500
-2,700
-1% -$199K 0.01% 1538
2015
Q4
$21.9M Buy
194,200
+101,900
+110% +$11.2M 0.01% 1067
2015
Q3
$10.9M Sell
92,300
-175,300
-66% -$22.9M ﹤0.01% 1747
2015
Q2
$20.7M Buy
267,600
+124,400
+87% +$8.16M 0.01% 1273
2015
Q1
$8.28M Sell
143,200
-6,200
-4% -$263K ﹤0.01% 2079
2014
Q4
$4.82M Buy
149,400
+45,900
+44% +$1.38M ﹤0.01% 2944
2014
Q3
$2.53M Buy
103,500
+40,600
+65% +$825K ﹤0.01% 4199
2014
Q2
$1.12M Buy
62,900
+19,300
+44% +$311K ﹤0.01% 5811
2014
Q1
$872K Buy
43,600
+26,400
+153% +$512K ﹤0.01% 5752
2013
Q4
$289K Buy
+17,200
New +$238K ﹤0.01% 7646
2013
Q3
Sell
-20,700
Closed -$116K 9299
2013
Q2
$116K Buy
+20,700
New +$125K ﹤0.01% 7733

Other funds holding ANAC

Jeff Yass's ANAC Position: Q2 2016 in Review

Jeff Yass sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 101,038 shares — an estimated $5.4M sold.

Jeff Yass first reported a position in ANAC in Q3 2013 and held it in 11 quarters. The position peaked at $37.3M in Q2 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Jeff Yass reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Jeff Yass sold 101,038 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $5.4M.
  • Jeff Yass first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2013 and held it in 11 quarters.
  • Jeff Yass's ANACOR PHARMACEUTICALS INC COM position peaked at $37.3M in Q2 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Susquehanna International Group's 13F filing for Q2 2016, filed 15 Aug 2016.